|
Vol. 35 Nš 8 |
Lat. Am. J. Pharm. 35 (8): 1697-1908 (2016) |
REGULAR ARTICLES |
|
|
Design, Synthesis and Biological Evaluation of 2-Thio Benzoxazole Derivatives as Anti-Inflammatory and Analgesic Agents *
YIN D., GAO X., LI Q., ZHAO N. & LONG S. (1701)
|
|
|
|
HPLC Method Validation for the Evaluation of Rosuvastatin: Application to Raw Material, Bulk and Pharmaceutical Products *
ALI H., ZAFAR F., SHAH S.N., MALLICK N., NAVEED S., NAQVI G.R., HASNAIN H., MAROOF K. & QURESH S. (1710)
|
|
|
|
Synergistic Effect of Melatonin and Atorvastatin in Type 1 Diabetic and Ischemic Injury Cardiomyopathic Sprague Dawley Rats *
ZHANG J., ZHANG Z., YANG B., JING X., ZHONG W. & TANG H. (1719)
|
|
|
|
Prescription Errors in Two Mexican Hospitals: Effect of the Use of a Computerized Prescription Order Entry *
NÚŅEZ-SÁNCHEZ A., CORNEJO-BRAVO J.M. & CARRILLO CEDILLO G. (1725)
|
|
|
|
Development of mPEG-PLA Based Polymeric Micelles for Controlled Release of Ginkgolide B: In Vitro Evaluation and Pharmacokinetic Study in Rats *
SONG L. & HE S. (1730)
|
|
|
|
Competitive Binding of Aspirin and Warfarin to Serum Albumin: a Fluorescence Quenching Study *
ZHANG W., LI L., ZHANG P., SHEN C., LI L., CHEN H. & HUANG X. (1737)
|
|
|
|
Quantification of Apixaban in Rat Plasma Using UPLC-MS/MS and its Application to a Pharmacokinetic Study *
JIN X., YANG Y., & HU M. (1748)
|
|
|
|
Preparation and Characterization of Chemically Cross-Linked pH Sensitive Poly (EHA-co-IA) Microgels for Controlled Delivery of Diltiazem HCl *
RAZZAQ R., RANJHA N.M., AITAZAZ H., RASHID Z. & RASHID R. (1754)
|
|
|
|
Effect of Myricetin on the Pharmacokinetics of Vortioxetine in Rats *
WANG H., WANG H., QIU J., ZHANG Z., & WANG H. (1763)
|
|
|
|
Response Surface Methodology Based Optimization of Robust RP-HPLC Method for Estimation of Sorafenib in Pharmaceutical Dosage Formulation *
AHMAD A., ALKHARFY K.M., RAISH M., ALRABIAH H., ALANAZI A.M. & WANI T.A. (1768)
|
|
|
|
Pharmacokinetic Study of Docetaxel after Intravenous Administration of Magnesium Isoglycyrrhizinate Injection in Rats by UPLC-MS-MS *
QU B., XING R., GE Q., CHEN X., ZHANG W., ZHAO Y., HU B., PENG D. & CHEN W. (1776)
|
|
|
|
In vivo Cytotoxicity of Polysubstituted Pyrazole Derivatives against Liver Cancer Cell Line *
FAHMY H.H., KHALIFA N.M., ISMAIL M.M.F., EL-SAHRAWY H.M., NOSSIER E.S., & ALI M.M. (1783)
|
|
|
|
Stability Indicating RP-UHPLC Method Development and Validation of Antipsychotic Drug Risperidone in Self Emulsifying Lipid and Solid Dosage Formulation *
ALQARNI H.M., KAZI M., AHMAD A., RAISH M. & ALANAZI F.K. (1791)
|
|
|
|
Pattern of Variable Pharmacokinetic of Clavulanic Acid from Oral Formulation of Co-Amoxiclav Alone and with Antacid in Healthy Subjects *
FATIMA A., NAQVI S.B., YOUNUS I., KHAN Z., KHALIQ S.A. & ALI S.M. (1799)
|
|
|
|
In situ Intestinal Absorption Kinetics of Carvedilol Nanosuspensions in Rats *
LIU D., LI J., HE F., WU Q., GE H., YANG X., YU S., WANG X., WANG X. & PAN H. (1805)
|
|
|
|
Simultaneous Determination of Five Rat CYP450 Probe Drugs by UPLC-MS/MS Method *
WEI Y., DU H., LIN Y., WU M., YING X., DING M. & HUANG H. (1810)
|
|
|
|
The Absolute Bioavailability and Food Effects on Pharmacokinetics of L-3-n-Butylphthalide Tablet in Healthy Chinese Subjects *
WANG M., LOU K., ZHANG Q., PENG Y., HUA W. & HUANG M. (1816)
|
|
|
|
Pharmacokinetics and Tolerability of Midazolam and Gender-Related Differences in Volunteers Using LC-MS/MS *
SOUZA FILHO J.H., BEDOR D.C.G., RAMOS V.L.S., SOUSA C.E.M., LEAL L.B. & SANTANA D.P. (1821)
|
|
|
|
Assessment of Potential Drug-Drug Interactions in Out-Patients Due to the Trends of Polypharmacy Prescriptions in Pakistan: a Retrospective Cross Sectional Design *
SYED M.A., HANIF S., JAVAID F., RAZAQ S., WAJAHAT I., SAJJAD S. & IJAZ M. (1829)
|
|
|
|
Novel Fatty Acid Synthase Inhibitors from the Vines of Polygonum multiflorum Thunb *
LIANG Y., TAN B. & GAO X. (1838)
|
|
|
|
Bisphenol F Diglycidyl Ether (BFDGE) Affects the Activity of Anti-Colon Cancer Drugs-Related Drug-Metabolizing Enzymes (DMEs) *
ZHOU Y., LIU Y. & LIU S. (1844)
|
|
|
|
A Study on the Combinational Effect of Cholinesterase Inhibitors and NDMA Receptor Antagonist with Herbal Therapy among AlzheimersDisease Patients *
ZHANG, Q. (1850)
|
|
|
|
Bergapten Attenuates Allergic Inflammation in Mast Cells Through Inhibition of Histamine Release and Pro-Inflammatory Cytokines *
ZHENG D. & CHEN L. (1855)
|
|
|
|
Nimesulide Sustained Release Matrix Pellets Prepared by Extrusion/Spheronization *
IBRAHIM M.A., HASSAN M.A., Al ENAZI N.A., MAHMOUD H.A. & EL-BADRY M. (1861)
|
|
|
|
Development and Validation of a Microplate Bioassay for Nystatin Using Analytical Quality by Design (QbD) Approach *
JAMIL C.R.P., LOURENĮO F.R., GHISLENI D.D.M. & PINTO T.J.A. (1871)
|
|
|
|
Pharmacokinetic Study and UPLC-MS/MS Method Development of Ibrutinib in Mouse *
LIU W., ZHENG X., CHEN K., JIAO Y., & WANG X. (1877)
|
|
|
|
Chemical Composition and Antimicrobial Activity of Volatile Oils of Piper amalago L. *
SANTOS V.L.P., LIMA C.O., CAMPOS R., RIBEIRO C.S.R., MARQUES F.A., BUDEL J.M. & MESSIAS-REASON I.J. (1883)
|
|
|
SHORT COMMUNICATIONS |
|
|
Synthesis of Pyran-Annulated Heterocycles Derivatives and Evaluation of Their Anti-Osteosarcoma Activity *
XUE L., CAO B., HOU H., YANG J., ZHANG J. & CHEN Y. (1890)
|
|
|
|
Determination of Irsogladine Using HPLC-ESI-MS/MS in Human Plasma: Application to Bioequivalence Study *
HOANG N., HUONG N., HONG S. & PARK J. (1894)
|
|
|
|
In vivo Characterization of Cefditoren Pivoxil Loaded Floating Microspheres *
CHILUKALA S., BONTHA V.K. & PRAGADA R.R. (1899)
|
|
|
|
In Vitro Evidence for Potential Clopidogrel-Propofol Interaction *
ZHANG L., LI H., GAO S., GUAN S., YANG S., YANG Z., SHI C., DAI T. & LI Z. (1903)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|